2005
DOI: 10.1016/j.joms.2004.12.007
|View full text |Cite
|
Sign up to set email alerts
|

Activation of platelet-rich plasma using thrombin receptor agonist peptide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
55
0
3

Year Published

2008
2008
2019
2019

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 62 publications
(58 citation statements)
references
References 21 publications
0
55
0
3
Order By: Relevance
“…At a minimum, any procedure developed to concentrate platelets should be able to show a sufficiently high concentrate of platelets to affect a clinical outcome and demonstrate high percentage of growth factor in the resulting concentrate, as well as a variable platelet population [3,21]. So in our study PRP was prepared from 10cc of patient's blood and centrifuged twice in a clinical tabletop digital centrifuge as advocated by Aron Gonshor [21], Regina Landesberg et al [24], Rick C Tsay et al [25].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…At a minimum, any procedure developed to concentrate platelets should be able to show a sufficiently high concentrate of platelets to affect a clinical outcome and demonstrate high percentage of growth factor in the resulting concentrate, as well as a variable platelet population [3,21]. So in our study PRP was prepared from 10cc of patient's blood and centrifuged twice in a clinical tabletop digital centrifuge as advocated by Aron Gonshor [21], Regina Landesberg et al [24], Rick C Tsay et al [25].…”
Section: Discussionmentioning
confidence: 99%
“…PRP can be activated with calcium chloride alone [15], calcium chloride along with bovine thrombin [4,25,26], human thrombin, autologous bone or autologous blood containing thrombin [21], TRAP (Thrombin Receptor Activator Peptide) [24,25] or ITA gelling agent [24].…”
Section: Discussionmentioning
confidence: 99%
“…Większość dostępnej literatury sugeruje konieczność aktywowania osocza bogatopłytkowego, głównie przez dodanie do uzyskanego PRP chlorku wapnia i/lub trombiny bydlęcej (rzadziej autogennej) (13). Innymi proponowanymi sposobami aktywacji trombocytów w PRP są: jego mrożenie (2) lub stosowanie syntetycznego peptydu podobnego do trombiny, nazywanego TRAP-6 (Thrombin Receptor Activator Peptide 6) (17,24).…”
Section: Osocze Bogatopłytkoweunclassified
“…Jej stosowanie w niektórych przypadkach powoduje powstanie przeciwciał przeciwko czynnikom krzepnięcia: V, XI i trombinie, co może prowadzić do rozwoju koagulopatii (4,11,17,24,27).…”
Section: Osocze Bogatopłytkoweunclassified
“…It comprises of 0.2% by volume of whole blood, which converts to an insoluble fibrin meshwork in the presence of thrombin [2]. There has always been a demand by surgeons for natural substances that would assist in arrest of bleeding and perfect closure of wound margins.…”
Section: Introductionmentioning
confidence: 99%